Literature DB >> 16807387

COX-2: a link between airway inflammation and disordered chloride secretion in cystic fibrosis?

A Clayton, A J Knox.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16807387      PMCID: PMC2104669          DOI: 10.1136/thx.2006.060293

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  22 in total

1.  Pulmonary disease severity in men with deltaF508 cystic fibrosis and residual chloride secretion.

Authors:  S R Thomas; A Jaffe; D M Geddes; M E Hodson; E W Alton
Journal:  Lancet       Date:  1999-03-20       Impact factor: 79.321

2.  Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers.

Authors:  A Van Hecken; J I Schwartz; M Depré; I De Lepeleire; A Dallob; W Tanaka; K Wynants; A Buntinx; J Arnout; P H Wong; D L Ebel; B J Gertz; P J De Schepper
Journal:  J Clin Pharmacol       Date:  2000-10       Impact factor: 3.126

Review 3.  Regulation of depth and composition of airway surface liquid.

Authors:  J H Widdicombe; S J Bastacky; D X Wu; C Y Lee
Journal:  Eur Respir J       Date:  1997-12       Impact factor: 16.671

4.  Interleukin-1beta differentially regulates beta2 adrenoreceptor and prostaglandin E2-mediated cAMP accumulation and chloride efflux from Calu-3 bronchial epithelial cells. Role of receptor changes, adenylyl cyclase, cyclo-oxygenase 2, and protein kinase A.

Authors:  Andrew Clayton; Elaine Holland; Linhua Pang; Alan Knox
Journal:  J Biol Chem       Date:  2005-04-15       Impact factor: 5.157

5.  Chloride conductance and genetic background modulate the cystic fibrosis phenotype of Delta F508 homozygous twins and siblings.

Authors:  I Bronsveld; F Mekus; J Bijman; M Ballmann; H R de Jonge; U Laabs; D J Halley; H Ellemunter; G Mastella; S Thomas; H J Veeze; B Tümmler
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

6.  Distinct sputum cytokine profiles in cystic fibrosis and other chronic inflammatory airway disease.

Authors:  E Osika; J M Cavaillon; K Chadelat; M Boule; C Fitting; G Tournier; A Clement
Journal:  Eur Respir J       Date:  1999-08       Impact factor: 16.671

7.  COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression.

Authors:  N V Chandrasekharan; Hu Dai; K Lamar Turepu Roos; Nathan K Evanson; Joshua Tomsik; Terry S Elton; Daniel L Simmons
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-19       Impact factor: 11.205

8.  Loss of CFTR chloride channels alters salt absorption by cystic fibrosis airway epithelia in vitro.

Authors:  J Zabner; J J Smith; P H Karp; J H Widdicombe; M J Welsh
Journal:  Mol Cell       Date:  1998-09       Impact factor: 17.970

9.  Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease.

Authors:  H Matsui; B R Grubb; R Tarran; S H Randell; J T Gatzy; C W Davis; R C Boucher
Journal:  Cell       Date:  1998-12-23       Impact factor: 41.582

10.  Upregulation of COX-1 and COX-2 in nasal polyps in cystic fibrosis.

Authors:  J Roca-Ferrer; L Pujols; S Gartner; A Moreno; F Pumarola; J Mullol; N Cobos; C Picado
Journal:  Thorax       Date:  2006-03-03       Impact factor: 9.139

View more
  2 in total

1.  Evidence of microvascular dysfunction in patients with cystic fibrosis.

Authors:  Paula Rodriguez-Miguelez; Jeffrey Thomas; Nichole Seigler; Reva Crandall; Kathleen T McKie; Caralee Forseen; Ryan A Harris
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-04-15       Impact factor: 4.733

2.  Prostaglandin-endoperoxide synthase genes COX1 and COX2 - novel modifiers of disease severity in cystic fibrosis patients.

Authors:  K Czerska; A Sobczynska-Tomaszewska; D Sands; A Nowakowska; D Bak; K Wertheim; J Poznanski; J Zielenski; A Norek; J Bal
Journal:  J Appl Genet       Date:  2010       Impact factor: 2.653

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.